Dr. Feras M. Abu Hantash, FACMG, CA-CGMB, NY- CoQ

Dr. Feras M. Abu Hantash has a diverse and extensive work experience in the field of molecular oncology and genetics. Dr. Feras M. is currently serving as the Senior Vice President-Clinical Laboratory Director at Harbinger Health, where they manage the clinical laboratory operations. Prior to this, they worked as a Consultant-CLIA Lab Director at the same company.

Before joining Harbinger Health, Dr. Abu Hantash held various positions at Sema4, a health information company. Dr. Feras M. served as the Senior Vice President of Molecular Oncology, leading the development of the somatic clinical oncology testing portfolio. Dr. Feras M. was responsible for test development, validation, NY-Approval, and implementation in CAP and CLIA lab environments, ensuring compliance with CLIA lab regulations and meeting CAP requirements. Additionally, they served as the Vice President of Molecular Oncology at Sema4.

Dr. Abu Hantash also has significant experience at Quest Diagnostics, where they held several roles over the course of their career. Dr. Feras M. served as the Senior Scientific Director in Hematology/Oncology at the Nichols Institute, overseeing the coordination and implementation of molecular oncology tests. Dr. Feras M. ensured compliance with CLIA lab regulations and CAP requirements. Dr. Feras M. also served as the Scientific Director in Diabetes and Cardiovascular Disease, Cardiovascular Diseases R&D, and as a Principal Scientist and Senior Scientist at the Nichols Institute.

In addition to their industry experience, Dr. Abu Hantash has served as the Editor-in-Chief of Recent Patents on DNA and Gene Sequences. Dr. Feras M. has also worked as a Research | Teaching Assistant | Assistant Instructor at the University of Texas at Austin and as a Research | Teaching Assistant at the University of New Hampshire. Dr. Feras M. began their career as a Scientific Assistant at Kuwait University.

Overall, Dr. Abu Hantash's work experience demonstrates their expertise in clinical laboratory management, molecular oncology testing, compliance with lab regulations, and research and teaching in molecular biology and genetics.

Dr. Feras M. Abu Hantash obtained their M.S. in Microbiology from the University of New Hampshire in 1992. Dr. Feras M. then completed their Ph.D. in Microbiology from the University of Texas at Austin in 1998. From 1998 to 2001, they served as a Postdoctoral Fellow at the University of Texas at Austin. In 2008, they attended UCLA as a Clinical Molecular Genetics Fellow.

Dr. Abu Hantash has also obtained several additional certifications. In 2011, they obtained a DABMG-Clinical Molecular Genetics certification from the American Board of Medical Genetics and Genomics. In 2015, they received a certification as a Clinical Genetic Molecular Biologist from the California Department of Public Health. Furthermore, they hold a Certificate of Qualification in Genetic Testing and Molecular Oncology, although the details of when and where they obtained this certificate are not provided.